NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Biocept Inc (NASDAQ: BIOC)

BIOC Technical Analysis
As on 26th Dec 2023 BIOC SHARE Price closed @ 0.07 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.86 & Strong Sell for SHORT-TERM with Stoploss of 1.00 we also expect STOCK to react on Following IMPORTANT LEVELS.


Open 0.03 Change Price %
High 0.07 1 Day 0.04 133.33
Low 0.03 1 Week -0.02 -22.22
Close 0.07 1 Month -0.13 -65.00
Volume 65116 1 Year -0.96 -93.20
52 Week High 6.65 | 52 Week Low 0.03
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
KZIA 0.67 %
NVDA 134.91 %
MAXN 0.21 %
TSLA 263.26 %
LMDX 0.02 0.00%
VRPX 1.70 %
LGVN 4.55 %
AMD 183.96 %
FFIE 0.40 %
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
BCAC 22.71 125.30%
CFFEW 0.11 120.00%
JCIC 22.08 116.68%
AMRS 0.14 100.00%
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AXAS 0.03 -70.00%
MILEW 0.06 -53.85%
ALF 0.01 -50.00%
ALF 0.01 -50.00%
LOTZW 0.01 -50.00%
ALACW 0.01 -50.00%
BTAQW 0.01 -50.00%
Daily Charts
Intraday Charts
Whats New @
Free Analysis
BIOC Important Levels Intraday
BIOC Forecast July 2024
4th UP Forecast0.84
3rd UP Forecast0.59
2nd UP Forecast0.44
1st UP Forecast0.29
1st DOWN Forecast-0.15
2nd DOWN Forecast-0.3
3rd DOWN Forecast-0.45
4th DOWN Forecast-0.7
BIOC Weekly Forecast
4th UP Forecast0.40
3rd UP Forecast0.29
2nd UP Forecast0.23
1st UP Forecast0.16
1st DOWN Forecast-0.02
2nd DOWN Forecast-0.09
3rd DOWN Forecast-0.15
4th DOWN Forecast-0.26
BIOC Forecast2024
4th UP Forecast25.89
3rd UP Forecast17.61
2nd UP Forecast12.49
1st UP Forecast7.37
1st DOWN Forecast-7.23
2nd DOWN Forecast-12.35
3rd DOWN Forecast-17.47
4th DOWN Forecast-25.75
BIOC Other Details
Segment EQ
Market Capital 56241860.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
BIOC Address
BIOC Latest News
Your Comments and Response on Biocept Inc
BIOC Business Profile
Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring in order to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreaticobiliary cancer, and ovarian cancer. Its Target-Selector molecular technology enables detection of mutations and genome alterations with enhanced sensitivity and specificity, as well as is applicable to nucleic acid from circulating tumor DNA; and Target-Selector CTC and molecular platforms provide biomarker detection and monitoring capabilities. In addition, it offers laboratory services to medical oncologists, neuro-oncologists, surgical oncologists, urologists, pulmonologists, pathologists, and other physicians. Further, it is developing PCR-based assays for detecting the COVID-19 virus. The company sells its cancer diagnostic assays directly to oncologists and other physicians at private and group practices, hospitals, laboratories, and cancer centers in the United States, as well as markets its clinical trial and research services to pharmaceutical and biopharmaceutical companies, and clinical research organizations. It has a partnership with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California. Address: 9955 Mesa Rim Road, San Diego, CA, United States, 92121
2005-2023 All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service